{"id":18651,"date":"2026-02-09T09:00:00","date_gmt":"2026-02-09T09:00:00","guid":{"rendered":"https:\/\/www.gecp.pt\/?p=18651"},"modified":"2026-02-08T23:08:10","modified_gmt":"2026-02-08T23:08:10","slug":"analise-ao-sangue-permite-antecipar-o-risco-de-recaida-no-cancro-do-pulmao-operavel","status":"publish","type":"post","link":"http:\/\/www.gecp.pt\/en\/analise-ao-sangue-permite-antecipar-o-risco-de-recaida-no-cancro-do-pulmao-operavel\/","title":{"rendered":"A blood test can help predict the risk of relapse in operable lung cancer"},"content":{"rendered":"<p>A study by the Spanish Lung Cancer Group (GECP), published in Clinical Cancer Research, demonstrates that a blood test capable of detecting Minimal Residual Disease (MRD) after surgery significantly improves the prediction of relapse risk.<\/p>\n<p>The results reveal that, although only 9.6% of patients were MRD-positive, all developed a relapse\u2014in many cases, up to 8 months before it was detectable by imaging tests.<\/p>\n<p>Mariano Provencio, president of GECP, emphasizes that, &#8220;if these results are confirmed in larger studies, we will be able to better personalize post-surgical treatments, avoiding unnecessary therapies and focusing efforts on those who really need them.&#8221;<\/p>\n<blockquote><p><a href=\"https:\/\/tinyurl.com\/5xv4d9fa\" rel=\"noopener\" target=\"_blank\">Read the full news article here.<\/a><\/p><\/blockquote>\n<p><\/p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>A study by the Spanish Lung Cancer Group (GECP), published in Clinical Cancer Research, demonstrates that a blood test capable of detecting Minimal Residual Disease (MRD) after surgery significantly improves the prediction of relapse risk. The results reveal that, although&#8230;<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>","protected":false},"author":1,"featured_media":18652,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"ngg_post_thumbnail":0},"categories":[118],"tags":[],"_links":{"self":[{"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts\/18651"}],"collection":[{"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/comments?post=18651"}],"version-history":[{"count":5,"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts\/18651\/revisions"}],"predecessor-version":[{"id":18659,"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts\/18651\/revisions\/18659"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/media\/18652"}],"wp:attachment":[{"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/media?parent=18651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/categories?post=18651"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/tags?post=18651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}